Ibu and Reflux laryngitis - a phase IV clinical study of FDA data

Summary:

Reflux laryngitis is reported as a side effect among people who take Ibu (ibuprofen), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Zantac, and have Eczema.

The phase IV clinical study analyzes which people have Reflux laryngitis when taking Ibu. It is created by eHealthMe based on reports of 240,078 people who have side effects when taking Ibu from the FDA, and is updated regularly.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is often used in pain. eHealthMe is studying from 246,532 Ibu users. Check the latest studies of Ibu.

What is Reflux laryngitis?

Reflux laryngitis (voice disorder caused by backflow of stomach fluids to the throat and voice box area) is found to be associated with 132 drugs and 192 conditions by eHealthMe. Check the latest studies of Reflux laryngitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

240,078 people reported to have side effects when taking Ibu.
Among them, 23 people (0.01%) have Reflux laryngitis.

Among these 23 people:

How long have people been on Ibu when they have Reflux laryngitis? *

What is the gender of people who have Reflux laryngitis when taking Ibu? *

female: 100 %
male: 0.0 %

What is the age of people who have Reflux laryngitis when taking Ibu? *

What are other drugs people take besides Ibu? *

What are other side effects people have besides Reflux laryngitis? *

Fatigue (feeling of tiredness): 18 people, 78.26%
Dizziness: 18 people, 78.26%
Rashes (redness): 16 people, 69.57%
Hair Loss: 16 people, 69.57%
Night Sweats (sweating in night): 15 people, 65.22%
Otitis (ear infection): 15 people, 65.22%
Laryngocele (a congenital anomalous air sac communicating with the cavity of the larynx): 15 people, 65.22%
Keloids (overgrown scars left from skin injuries): 15 people, 65.22%
Hodgkin's Lymphoma (cancer originating from white blood cells): 15 people, 65.22%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 15 people, 65.22%

What are the existing conditions these people have? *

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 15 people, 65.22%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 17.39%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 13.04%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 13.04%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 13.04%
High Blood Pressure: 2 people, 8.70%
Dyslipidaemia (abnormal amount of lipids): 2 people, 8.70%
Drowsiness: 2 people, 8.70%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 4.35%
Diabetes: 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Ibu and have Reflux laryngitis?

- Check whether Reflux laryngitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ibu:

Ibu (246,532 reports)

Browse all side effects of Ibu:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Reflux laryngitis:

Reflux laryngitis (132 drugs)

Browse all the conditions that are associated with Reflux laryngitis:

Reflux laryngitis (192 conditions)

Related publications that referenced our studies

Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .
Moslim MA, Sodeman TC, Nawras AT, "A Case of Suggested Ibuprofen-Induced Acute Pancreatitis", American journal of therapeutics, 2016 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on ibuprofen (the active ingredients of Ibu) and Ibu (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.